GGD6 (Azithromycin monohydrate 250 mg)
Pill imprint GGD6 has been identified as Azithromycin monohydrate 250 mg.
Azithromycin is used in the treatment of chlamydia infection; bacterial infection; sinusitis; bronchitis; upper respiratory tract infection (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GGD6
- 250 mg
- 15.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|58016-4814||Southwood Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about azithromycin
- Azithromycin single-dose packet
- Azithromycin suspension
- Azithromycin tablets
- Azithromycin (Advanced Reading)
- Azithromycin Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.